Sygnis   
德国Sygnis制药公司的旗舰产品Qualiphi是一个可用于完整DNA扩增的聚合酶，是长DNA片段和全基因组扩增的主要工具之一。

SYGNIS Pharma AG is a biotech company listed in the Prime Standard of the German Stock Exchange. According to the 2012 newly defined business strategy, the company focuses on the development and marketing of novel technologies in molecular biology, e.g. in the field of DNA amplification and sequencing. For the key product “Qualiphi®”, an improved polymerase for amplifying DNA, an exclusive worldwide license has been granted to Qiagen in July 2012.